Scientists Tweaked LSD's Molecular Structure and Created a Wild New Brain Drug
A team of researchers at the University of California, Davis, made small tweaks to the molecular structure of lysergic acid diethylamide (LSD) to see if it could be turned into an effective brain-healing treatment for patients that suffer from conditions like schizophrenia — without risking a potentially disastrous acid trip.
As detailed in a new paper published in the journal Proceedings of the National Academy of Sciences last month, the researchers created a new compound called JRT by shifting the position of just two atoms of the psychedelic's molecular structure.
With the two atoms flipped, the new drug could still stimulate brain cell growth and repair damaged neural connections, while simultaneously minimizing psychedelic effects, in mice.
"Basically, what we did here is a tire rotation," said corresponding author and UC Davis chemistry professor David Olson in a statement. "By just transposing two atoms in LSD, we significantly improved JRT's selectivity profile and reduced its hallucinogenic potential."
In experiments involving mice, the team found that JRT improved negative symptoms of schizophrenia without worsening other behaviors associated with psychosis.
While it's still far too early to tell if JRT could be effective in humans as well, the team is hoping that the new drug could become a powerful new therapeutic, especially for those suffering from conditions like schizophrenia.
"No one really wants to give a hallucinogenic molecule like LSD to a patient with schizophrenia," said Olson. "The development of JRT emphasizes that we can use psychedelics like LSD as starting points to make better medicines."
"We may be able to create medications that can be used in patient populations where psychedelic use is precluded," he added.
Olsen and his colleagues hope their new drug could provide an alternative to drugs like clozapine, a schizophrenia treatment, without negative side effects like an inability to feel pleasure and a decline in cognitive function.
Interestingly, it also proved a powerful antidepressant in early experiments involving mice at doses 100-fold lower than ketamine, a popular anesthetic used for the treatment of depression and pain management.
But before it can be tested in humans, the team still has plenty of work to do.
"JRT has extremely high therapeutic potential," Olsen said in the statement. Right now, we are testing it in other disease models, improving its synthesis, and creating new analogs of JRT that might be even better."
More on LSD: Former CEO Sues Company That Fired Him for Microdosing LSD in an Investor Meeting
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Statewide Mobile Monitoring Initiative launched to help guide air quality improvement
( — California Governor Gavin Newsom announced the launch of the Statewide Mobile Monitoring Initiative program, created to guide air quality improvement efforts in California. Video Above: Gov. Newsom announced CalHeatScore, a tool to help people understand the severity of heat waves 'While the federal government threatens to take us back to the days of smoggy skies and clogged lungs, California continues to lead the way,' Newsom said. 'We're deploying first-of-their-kind vehicles to monitor pollution levels at a block-by-block level, delivering critical air quality information to communities across the state.' The program delivers hyper-local air pollution data by deploying mobile air monitoring equipment to 64 communities that have been facing environmental disparities in the state. The deployment of the monitoring equipment will begin in June, with the use of sensor-equipped vehicles from Aclima and mobile laboratories operated by researchers from the University of California, Berkeley; the University of California, Riverside and Aerodyne. The organizations involved plan on collecting and analyzing data on local pollution levels. The initiative comes along with the statewide effort, California Climate Investments, that puts billions of Cap-and-Invest dollars into reducing greenhouse gas emissions, strengthening the economy, and improving public health and the environment. Priority populations, such as low-income communities and communities facing disproportionate pollution burdens, will be more than 60% of the areas monitored, the office of Newsom said. Elk Grove to welcome 2 new fast food chain locations 'By meeting communities where they are and listening to their concerns, we're building an air quality monitoring system that integrates the lived experiences of the people most impacted by air pollution,' said CARB Executive Director Dr. Steven Cliff. 'The Statewide Mobile Monitoring Initiative represents an unprecedented opportunity to gather the detailed information we need to better protect public health in neighborhoods that have historically borne the brunt of environmental injustice.' The project is expected to be completed by June of 2026, along with the public availability of the collected data. The data will then be used by CARB, local air districts, stakeholders and community stakeholders to properly address emerging pollution concerns. 'The data is also expected to inform future regulatory programs, academic research, and applications for grants such as the Community Air Grants Program,' said the office. The state's clean air efforts have also saved $250 billion in health costs through reduced illness and reduced diesel-related cancer risk by almost 80 percent, according to the office. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
a day ago
- Business Wire
Lieff Cabraser & Farella Braun + Martel Announce That University of California Researchers Have Filed a Class Action Lawsuit Against the Trump Administration for the Illegal and Unconstitutional Termination of Critical Research Grants
SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser & Farella Braun + Martel Announce that a group of six University of California faculty and other researchers have filed a class action in federal court against the Trump Administration on behalf of all UC researchers whose previously approved agency grants were terminated pursuant to Executive Orders or other directives of President Trump, as implemented through the Department of Government Efficiency ('DOGE'). University of California Researchers File Class Action Suit Against Trump Administration for Illegal & Unconstitutional Termination of Critical Research Grants Plaintiffs seek a declaration that these grant terminations violate the constitutional principle of separation of powers, the First Amendment guarantee of free speech, and the Fifth Amendment guarantee of due process, as well as statutes that govern agencies' missions and grantmaking and the Administrative Procedure Act. As detailed in the Complaint, these abrupt cancellations of already awarded grants 'ignored or contradicted the purposes for which Congress created the granting agencies and appropriated funds, and dispensed with the regular procedures and due process afforded grantees under the Administrative Procedure Act, in implementing the Trump Administration's political 'cost-cutting' agenda and ideological purity campaign.' According to UC Berkeley Law Dean Erwin Chemerinsky, a leading constitutional law scholar and co-counsel on the case, 'President Trump and DOGE have arbitrarily cut off funding to researchers throughout the University of California system in clear violation of the Constitution and federal laws. There has not been a semblance of due process or compliance with the procedures required by federal statutes and regulations. This has caused great harm to a large number of faculty and other researchers and the UC research enterprise as a whole, with potentially grave consequences to everyone in society who benefits from the research in a myriad of disciplines." As described by Plaintiff Dr. Neeta Thakur, a pulmonary and critical care specialist at UCSF, 'The EPA has abruptly terminated a three-year grant that was supporting research on how wildfire smoke affects the lungs, heart, and brain of all Californians. My colleagues and I at UCSF and UC Berkeley have worked on this important project for two years, and its sudden end — communicated through a simple form letter — puts our progress in danger. This decision disrupts our ongoing work with community-based organizations and stops us from generating life-saving information designed to improve public health and protect the well-being of all Californians, especially those living in at-risk communities.' Plaintiff Jedda Foreman, the Director of the Center for Environmental Learning at the Lawrence Hall of Science at UC Berkeley, explains, 'My team and I at the Lawrence Hall of Science earned NSF grants to make science education more accessible to all learners. Instilling a love of science is critical to envisioning and creating a better future for us all. In one day, we lost two projects, and nearly 75% of our funding, because of terminations by NSF. A week later, NSF terminated yet another one of our projects. These terminations haven't just affected our team, but also our longtime community partners and thousands of students across the United States.' These are just two of hundreds of examples of the damage wrought by the Trump Administration's illegal and unconstitutional terminations. The lawsuit, filed in the U.S. District Court for the Northern District of California in San Francisco, seeks a return to the pre-Trump Administration process of orderly grantmaking that aligns with congressionally authorized purposes, and affords due process to grant-funded researchers. Plaintiffs seek, for themselves and the class of UC researchers who have suffered unlawful grant terminations, an injunction restoring their lost funding, providing them sufficient time to complete the work for which their grants were originally approved, and preventing further illegal grant terminations. Plaintiffs will be filing a motion for a temporary restraining order on June 5, 2025. The case, No. 3:25-cv-4737, is assigned to the Honorable Rita F. Lin. Background on the Lawsuit Each year, researchers in the UC system receive hundreds of millions of dollars in grants from the full spectrum of federal agencies, ranging from the Environmental Protection Agency, to the National Science Foundation, to the National Institutes of Health. These grants fund the production of new knowledge and fuel the development of discoveries that greatly benefit society at large. The grants have also been key to the innovation that has consistently earned the UC system pride of place among research institutions, including first place in the list of universities with the most utility patents. They have also made the UC Berkeley campus the number one ranked public research in institution in the world for nine of the past ten years. Before President Trump took office, federal grantmaking proceeded under the authority of Congress, which appropriated taxpayer funds for specific public purposes. For decades, agencies carried out these statutory directives and observed due process in making, renewing, and (only seldom) terminating grants. They each adhered to their own grant regulations and followed Administrative Procedure Act processes when modifying such regulations. On the rare occasions when agencies terminated grants, they did so pursuant to predictable, regularized processes and terminated grants only for reasons stated in the regulations. All of this changed abruptly on January 20, 2025 (Inauguration Day). After January 20, 2025, Defendants Donald J. Trump and DOGE, through a flurry of Executive Orders and other directives, commanded the Federal Agency Defendants to terminate scores of previously awarded research grants. As the Complaint notes, the 'abrupt, wholesale, and unilateral termination of these grants has violated the Constitution's bedrock principle of separation of powers and its guarantees of freedom of speech and due process; flouted the Impoundment Control Act limits on the Executive's ability to withhold or redirect congressionally appropriated money; ignored statutory requirements that agencies fulfill their substantive missions and fund congressionally specified activities; contravened agency-specific grant-making regulations that cannot by law be revised on an abrupt, unexplained, chaotic basis; and violated the Administrative Procedure Act through this arbitrary, capricious, and ultra vires conduct.' As further detailed in the Complaint, grounds the agencies have offered for such terminations were spurious. In some cases, agency correspondence to grantees asserted that grant termination would reduce public costs and promote government efficiency, although no evidence was provided to support this claim. In other cases, agency communications made it clear that grants were being terminated to further Defendant Trump's political objectives, which included the elimination of research on climate, environmental justice, 'gender ideology,' and 'DEI.' These grant terminations are occurring not because the grant-funded research departed from its originally approved purpose, but because that purpose now offends the political agenda and ideological requirements of the Trump Administration. In terminating these grants, the agencies have violated the Constitution, numerous federal statutes, and their own regulations. Plaintiff UC researchers have suffered concrete financial, professional, and other harms from Defendants' unilateral termination of grants for projects to which they have already dedicated time and effort; for research upon which they have staked careers and reputations; and for work with research teams through which they endeavored to train a next generation. These terminations have impaired and will impair the public-serving research mission of the UC system and the concern for public welfare that undergirds it. Named Plaintiffs and the Proposed Class will continue to suffer such harms on an ongoing basis, and will experience increasing and irreparable harm absent the court declaration and injunction they seek through this lawsuit.
Yahoo
a day ago
- Yahoo
Eating this popular fruit daily may support postmenopausal heart and metabolic health
Eating fresh mango every day may help to boost women's postmenopausal heart and metabolic health, researchers said Tuesday. They found that eating about 1.5 cups of the sweet fruit a day for two weeks significantly reduced blood pressure and cholesterol among postmenopausal women living with obesity. Both blood pressure and cholesterol are key indicators of heart health. 'Risk factors like high blood pressure and unhealthy cholesterol are key contributors to cardiovascular disease, but a nutrient-rich diet that includes fresh fruit, like mango, has long been shown to help reduce those risks,' Dr. Roberta Holt, an associate researcher at UC Davis, said in a statement. 'This study shows that even short-term changes — like eating fresh mangos daily — can make a measurable impact on chronic disease risk in certain populations.' Holt was a co-author of the research which was published Tuesday in the Journal of the American Nutrition Association. The study was supported through an unrestricted grant from the National Mango Board, although the board had no influence over the study. To reach these conclusions, they examined the health of 24 women between the ages of 50 to 70 years old who were overweight or obese. Before the study period, the authors instructed them to refrain from eating mangos. Over two weeks, the researchers collected baseline measurements, measurements when consumption began during a second visit to their lab, and then more measurements at the third visit. The women ate mangos in the mornings and the evenings. Two hours after consumption, their resting blood pressure dropped and there was a reduction in average arterial pressure. After consuming mangos every day for two weeks, their total cholesterol was slashed by nearly 13 points and their bad cholesterol dropped by the same amount. A smaller follow-up with just six participants from the initial study examined insulin and sugar levels after eating the same amount of mango with 83 grams of white bread. The researchers found the women's blood sugar levels rose significantly less after eating mango than after eating white bread. Insulin levels also responded more favorably to mango. Although mangos are high in natural sugar compared to other fruits, they also provide crucial vitamins and other nutrients. Additional research is needed to determine the effects of mango consumption of heart and metabolic health, but the benefits could aid the 1.3 million U.S. women undergoing menopause: a period when the risk of heart disease rises significantly. Women spend up to 40 percent of their lives in this life stage, and nearly half of American women are affected by cardiovascular disease. 'Post-menopausal women face distinct metabolic changes that can impact their risk of developing cardiovascular disease,' said Holt. 'These findings help to identify targeted dietary strategies, like eating fresh mangos daily, to aid this at-risk population and support cardiovascular wellness and potential reductions in chronic disease risk.'
